Lin Zhang
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 18
- Neurology top 0.5%
- Long-Term Effects of COVID-19 17
- Parkinson's Disease Mechanisms and Treatments 12
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 19
- Biological Psychiatry top 5%
-
- Liver Disease Diagnosis and Treatment 9
- Cervical Cancer and HPV Research 9
-
- Reproductive Biology and Fertility 9
-
- COVID-19 and Mental Health 8
- Co-authors
- Xinghuan WangZhibing LuYongzhen FanTao GuoJing WanMing ChenHairong WangXiaoyan Wu
- Cited by
- Infectious DiseasesNeurologyOncology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lin Zhang
280 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Infectious Diseases 2.7k
- Neurology 1.9k
- Oncology 1.9k
- Cardiology and Cardiovascular Medicine 982
- Biological Psychiatry 94
Countries citing papers authored by Lin Zhang
This map shows the geographic impact of Lin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhang more than expected).
Fields of papers citing papers by Lin Zhang
This network shows the impact of papers produced by Lin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhang. The network helps show where Lin Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 22 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 0 | |
| 14 | 2021 | 5 | |
| 15 | Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma | 2019 | 1 |
| 16 | 2014 | 4 | |
| 17 | [Comparative study of sexual behaviors of high school students between urban and rural China]. | 2013 | 4 |
| 18 | 2013 | 3 | |
| 19 | Study on health literacy and its influencing factors among Wuhan residents in 2011 | 2012 | 1 |
| 20 | Research on Mining Association Rule Based on Improved Apriori Algorithm | 2006 | 1 |
About Lin Zhang
Lin Zhang is a scholar working on Neurology, Oncology and Obstetrics and Gynecology, having authored 306 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), COVID-19 Clinical Research Studies (18 papers), Long-Term Effects of COVID-19 (17 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Liver Disease Diagnosis and Treatment (9 papers), Cervical Cancer and HPV Research (9 papers), Reproductive Biology and Fertility (9 papers) and COVID-19 and Mental Health (8 papers). The work is most often cited by research in Infectious Diseases (2.7k citations), Neurology (1.9k citations) and Oncology (1.9k citations). Lin Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xinghuan Wang, Zhibing Lu, Yongzhen Fan, Tao Guo, Jing Wan, Ming Chen, Hairong Wang, Xiaoyan Wu, Tao He and Martin C. S. Wong. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.